ImmunoPrecise Antibodies (IPA) Short Interest Ratio & Short Volume → The most important AI company you've never heard of (From Manward Press) (Ad) Free IPA Stock Alerts $1.15 -0.05 (-4.17%) (As of 05/15/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media ImmunoPrecise Antibodies Short Interest DataCurrent Short Volume311,500 sharesPrevious Short Volume340,000 sharesChange Vs. Previous Month-8.38%Dollar Volume Sold Short$392,490.00Short Interest Ratio / Days to Cover0.5Last Record DateApril 30, 2024Outstanding Shares26,320,000 sharesFloat Size21,520,000 sharesShort Percent of Float1.45%Today's Trading Volume89,899 sharesAverage Trading Volume423,676 sharesToday's Volume Vs. Average21% Short Selling ImmunoPrecise Antibodies ? Sign up to receive the latest short interest report for ImmunoPrecise Antibodies and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatIPA Short Interest Over TimeIPA Days to Cover Over TimeIPA Percentage of Float Shorted Over Time Ad Birch GoldWATCH: The Truth About InflationThe full story on inflation is being CENSORED by the powers that be. But I have the REAL monthly numbers. And they are going to anger you. (Especially if you have money sitting in a 401k or IRA.)WATCH: The Truth About Inflation ImmunoPrecise Antibodies Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024311,500 shares $392,490.00 -8.4%1.5%0.5 $1.26 4/15/2024340,000 shares $421,600.00 +6.9%1.6%0.6 $1.24 3/31/2024318,200 shares $483,664.00 -27.8%1.5%0.5 $1.52 3/15/2024440,700 shares $634,608.00 +1,290.2%2.0%0.8 $1.44 2/29/202431,700 shares $58,328.00 -37.6%0.2%0.1 $1.84 2/15/202450,800 shares $100,584.00 +232.0%0.2%0.4 $1.98 Get the Latest News and Ratings for IPA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ImmunoPrecise Antibodies and its competitors with MarketBeat's FREE daily newsletter. 1/31/202415,300 shares $27,693.00 -38.3%0.1%0.1 $1.81 1/15/202424,800 shares $41,168.00 +31.2%0.1%0.2 $1.66 12/31/202318,900 shares $32,319.00 -34.8%0.1%0.2 $1.71 12/15/202329,000 shares $40,020.00 +2.1%0.1%0.3 $1.38 11/30/202328,400 shares $44,588.00 -2.1%0.1%0.3 $1.57 11/15/202329,000 shares $42,050.00 -38.3%0.1%0.4 $1.45 10/31/202347,000 shares $108,269.20 +99.2%0.2%0.7 $2.30 10/15/202323,600 shares $30,208.00 -48.3%0.1%0.4 $1.28 9/30/202345,600 shares $83,448.00 +2.9%0.2%1 $1.83 9/15/202344,300 shares $77,968.00 -2.0%0.2%1 $1.76 8/31/202345,200 shares $85,428.00 +52.2%0.2%1.1 $1.89 8/15/202329,700 shares $67,315.05 -24.0%0.1%0.8 $2.27 7/31/202339,100 shares $98,532.00 -22.6%0.2%0.5 $2.52 7/15/202350,500 shares $142,410.00 -3.6%0.2%0.6 $2.82 6/30/202352,400 shares $155,104.00 -46.0%0.2%0.6 $2.96 6/15/202397,000 shares $280,330.00 -1.2%0.4%1.1 $2.89 5/31/202398,200 shares $310,312.00 +0.3%0.4%1.1 $3.16 5/15/202397,900 shares $299,574.00 No Change0.4%1.1 $3.06 10/31/2022129,400 shares $643,118.00 -12.5%N/A8 $4.97 10/15/2022147,800 shares $691,704.00 +41.8%N/A9 $4.68 9/30/2022104,200 shares $415,758.00 +17.6%N/A6.4 $3.99 9/15/202288,600 shares $430,596.00 -19.3%N/A5.6 $4.86 8/31/2022109,800 shares $585,234.00 -29.8%N/A7.4 $5.33 8/15/2022156,400 shares $828,920.00 -16.4%1.0%9.7 $5.30 7/31/2022187,100 shares $791,433.00 -6.7%1.1%11.7 $4.23 7/15/2022200,600 shares $762,280.00 -9.1%1.2%12.7 $3.80 6/30/2022220,600 shares $838,280.00 -4.8%1.3%10.5 $3.80 6/15/2022231,700 shares $919,849.00 -3.8%1.4%9.2 $3.97 5/31/2022240,800 shares $1.38 million +6.2%1.5%8.1 $5.73 5/15/2022226,800 shares $1.01 million -22.1%1.4%7.4 $4.45 4/30/2022291,300 shares $1.62 million -0.2%1.8%8.5 $5.56 4/15/2022291,900 shares $1.67 million +3.4%1.8%7.8 $5.72 3/31/2022282,200 shares $1.45 million +2.2%N/A0 $5.14 3/15/2022276,200 shares $1.09 million +0.2%1.6%7.5 $3.95A ‘DeFi Summer’ Projected! (Ad)Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x!Just click here to learn how you can access this coin right now. IPA Short Interest - Frequently Asked Questions What is ImmunoPrecise Antibodies' current short interest? Short interest is the volume of ImmunoPrecise Antibodies shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 311,500 shares of IPA short. 1.45% of ImmunoPrecise Antibodies' shares are currently sold short. Learn More on ImmunoPrecise Antibodies' current short interest. What is a good short interest percentage for ImmunoPrecise Antibodies? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.45% of ImmunoPrecise Antibodies' floating shares are currently sold short. Is ImmunoPrecise Antibodies' short interest increasing or decreasing? ImmunoPrecise Antibodies saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 311,500 shares, a drop of 8.4% from the previous total of 340,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ImmunoPrecise Antibodies' float size? ImmunoPrecise Antibodies currently has issued a total of 26,320,000 shares. Some of ImmunoPrecise Antibodies' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ImmunoPrecise Antibodies currently has a public float of 21,520,000 shares. How does ImmunoPrecise Antibodies' short interest compare to its competitors? 1.45% of ImmunoPrecise Antibodies' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to ImmunoPrecise Antibodies: Viracta Therapeutics, Inc. (2.54%), Daré Bioscience, Inc. (0.29%), Apollomics, Inc. (0.19%), Aprea Therapeutics, Inc. (1.90%), Acurx Pharmaceuticals, Inc. (4.67%), Theratechnologies Inc. (0.10%), NRx Pharmaceuticals, Inc. (6.36%), BriaCell Therapeutics Corp. (4.76%), Fortress Biotech, Inc. (12.69%), Spruce Biosciences, Inc. (0.97%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short ImmunoPrecise Antibodies stock? Short selling IPA is an investing strategy that aims to generate trading profit from ImmunoPrecise Antibodies as its price is falling. IPA shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ImmunoPrecise Antibodies? A short squeeze for ImmunoPrecise Antibodies occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IPA, which in turn drives the price of the stock up even further. How often is ImmunoPrecise Antibodies' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IPA, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: VIRX Short Squeeze DARE Short Squeeze APLM Short Squeeze APRE Short Squeeze ACXP Short Squeeze THTX Short Squeeze NRXP Short Squeeze BCTX Short Squeeze FBIO Short Squeeze SPRB Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IPA) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTop 5 AI Stocks to Buy for 2024Market Moving TrendsThis unknown company solves the biggest issue with AIManward PressTrump’s “Tax Free” Retirement Strategy Gold Safe Exchange